Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Certain symptoms and patient profiles, like thoracic pain and general malaise, increase the risk of COVID-19 patients being readmitted to the emergency department.

Physical activity increased, but sedentary behavior also rose, especially in men.

COVID-19 can cause significant hair loss.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Long COVID patients have more health issues than non-infected people.

As women age, hair follicles decrease in number and hair width tends to reduce.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Females are more affected by immune-related skin diseases, needing targeted health interventions.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

COVID-19 patients with hair loss experienced more cognitive issues and these issues were linked to higher levels of depression, anxiety, and stress.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.

Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

Testosterone may influence COVID-19 severity and outcomes.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.